In vitro, lenalidomide inhibited Treg proliferation and diminished FoxP3 expression in the absence of measurable effects on TGF-β or IL-10 production, while reducing Treg cell accumulation in lymph nodes of CT26 cancer-bearing animals [56]. Here, FOXP3 is linked to cancer.